1 documents found
Information × Registration Number 0205U002195, 0102U000209 , R & D reports Title Study of the pharmaco- and toxicodynamic characteristics of the new Ca2+ antagonist for its inculcation in healthcare practise. popup.stage_title Head Mochort N, Registration Date 04-02-2005 Organization Institute of Pharmacology and Toxicology Academy of Medical sciences of Ykraine popup.description2 The drug form of 0.01 g tablet based on the new combination of dihydropyridynes has been created and its pharmacological and toxicological properties have been studied. It is shown the new preparation proved the expressed antianginal effect, hypotensive and antiarrhythmic action causes small negative inotropic effect. On safe indices it belongs to low toxic combination , in prolonged administration it doesn't promote the negative influence on functions of the vitely important organs and systems. Product Description popup.authors popup.nrat_date 2020-04-02 Close
R & D report
Head: Mochort N. Study of the pharmaco- and toxicodynamic characteristics of the new Ca2+ antagonist for its inculcation in healthcare practise.. (popup.stage: ). Institute of Pharmacology and Toxicology Academy of Medical sciences of Ykraine. № 0205U002195
1 documents found

Updated: 2026-03-16